5.51MMarket Cap-0.02P/E (TTM)
1.3400High1.2200Low171.36KVolume1.3100Open1.2950Pre Close219.83KTurnover3.92%Turnover Ratio0.00P/E (Static)4.37MShares16.625052wk High1.74P/B5.51MFloat Cap0.923752wk Low--Dividend TTM4.37MShs Float6085800000.0000Historical High--Div YieldTTM9.27%Amplitude0.9230Historical Low1.2820Avg Price1Lot Size
Nuwellis Stock Forum
Revolutionary Heart Failure Treatment Cuts Patient Events by 60% - New Study Reveals Why It Matters
On January 29, Nuwellis Posted On X "Big News! As of January 1, 2025, the Reimbursement for Aquadex Just Quadrupled Under APC 5242, Making It a Game-changer for Outpatient Care! Are You Ready to Lead the Way in Patient Treatment and Maximize Your...
Benzinga· 6 mins ago1min
Nuwellis(NUWE.US)
On January 29, Nuwellis Posted On X "Big News! As of January 1, 2025, the Reimbursement for Aquadex Just Quadrupled Under APC 5242, Making It a Game-changer for Outpatient Care! Are ...
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy
Monday, 13th January at 8:00 am
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, is pleased to announce its newest pediatric hospital customer, a nationally ranked hospital in Utah. The hospital, Nuwellis' 44th pediatric account, will be utilizing t...
No comment yet